EC Number | Application | Comment | Organism |
---|---|---|---|
5.4.2.11 | medicine | mutation M230I is identified in a patient with hereditary sperocytosis and 50% deficiency of enzyme activity in red blood cells. Enzyme shows abnormal behaviour on ion-exchange chromatography and is more thermo-labile than wild-type | Homo sapiens |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
5.4.2.11 | M230I | mutation identified in a patient with hereditary sperocytosis and 50% deficiency of enzyme activity in red blood cells. Enzyme shows abnormal behaviour on ion-exchange chromatography and is more thermo-labile than wild-type | Homo sapiens |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
5.4.2.11 | 0.4 | - |
3-phospho-D-glycerate | pH 7.4, 30°C | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
5.4.2.11 | Homo sapiens | - |
patient with hereditary sperocytosis and 50% deficiency of enzyme activity in red blood cells | - |
EC Number | Reaction | Comment | Organism | Reaction ID |
---|---|---|---|---|
5.4.2.11 | 2-phospho-D-glycerate = 3-phospho-D-glycerate | ping-pong or phosphoenzyme mechanism | Homo sapiens |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
5.4.2.11 | erythrocyte | hemoglobin-free hemolysate | Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
5.4.2.11 | 2-phospho-D-glycerate | - |
Homo sapiens | 3-phospho-D-glycerate | - |
r | |
5.4.2.11 | 3-phospho-D-glycerate | - |
Homo sapiens | 2-phospho-D-glycerate | - |
r | |
5.4.2.11 | additional information | enzyme possesses some 2,3-bisphosphoglycerate phosphatase activity | Homo sapiens | ? | - |
? |
EC Number | Temperature Stability Minimum [°C] | Temperature Stability Maximum [°C] | Comment | Organism |
---|---|---|---|---|
5.4.2.11 | 45 | - |
wild-type, 1 h, 10% loss of activity, mutant M230I, 20 min, 50% loss of activity, 1 h, 90% loss of activity. In presence of 2,3-bisphosphoglycerate, both forms remain stable | Homo sapiens |